share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

默沙東 | 4：持股變動聲明-董事 GLOCER THOMAS H
美股sec公告 ·  06/05 02:38
牛牛AI助理已提取核心訊息
Thomas H. Glocer, associated with Merck & Co., Inc., executed a transaction involving the company's common stock on May 31, 2024. The action involved a direct holding of shares, with the number of shares beneficially owned following the transaction totaling 5,100. The nature of the shares is direct, indicating personal ownership by Glocer. The transaction details, including the price and total value of the shares, were not disclosed in the announcement.
Thomas H. Glocer, associated with Merck & Co., Inc., executed a transaction involving the company's common stock on May 31, 2024. The action involved a direct holding of shares, with the number of shares beneficially owned following the transaction totaling 5,100. The nature of the shares is direct, indicating personal ownership by Glocer. The transaction details, including the price and total value of the shares, were not disclosed in the announcement.
與默沙東藥廠有關的Thomas H. Glocer於2024年5月31日進行了一筆與該公司普通股有關的交易。此舉涉及持有的股份，交易後該股份的實益所有權總數為5,100股。股份的性質是直接的，表明Glocer個人擁有。交易詳情，包括股份的價格和總價值，在宣佈中未公開。
與默沙東藥廠有關的Thomas H. Glocer於2024年5月31日進行了一筆與該公司普通股有關的交易。此舉涉及持有的股份，交易後該股份的實益所有權總數為5,100股。股份的性質是直接的，表明Glocer個人擁有。交易詳情，包括股份的價格和總價值，在宣佈中未公開。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。